PIK3CG and neoplasm: PI3K are believed to be one of the key therapeutic targets for cancer treatment based on the observation that hyperactivity of PI3K signaling is significantly correlated with human tumor progression, increased tumor microvessel density and enhanced chemotaxis and invasive potential of cancer cells.